AI
ALT icon

Atria Investments’s Altimmune ALT Stock Holding History

Atria Investments’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$57.8K Buy
+19,017
New +$56.8K ﹤0.01% 2105
2025
Q2 		– Sell
-12,285
Closed -$61.4K – 1984
2025
Q1 		$61.4K Buy
+12,285
New +$77.8K ﹤0.01% 1881
2024
Q3 		– Sell
-13,060
Closed -$86.8K – 1900
2024
Q2 		$86.8K Buy
+13,060
New +$96.4K ﹤0.01% 1875

Other funds holding ALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Atria Investments's ALT Position: Q2 2026 in Review

Atria Investments opened a new position in Altimmune (ALT) in Q2 2026: 19,017 shares worth $57.8K. The stake represents ﹤0.01% of the portfolio and ranks #2105 among its holdings. This is a return to the name: Atria Investments previously reported a position in ALT as recently as Q1 2025.

Atria Investments first reported a position in ALT in Q2 2024 and has held it in 3 quarters since. The position peaked at $86.8K in Q2 2024. 210 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • Atria Investments held 19,017 shares of Altimmune worth $57.8K as of Q2 2026.
  • Altimmune was a new Atria Investments position in Q2 2026.
  • Altimmune made up ﹤0.01% of Atria Investments's portfolio in Q2 2026, its #2105 holding.
  • Atria Investments first reported a position in Altimmune in Q2 2024 and has held it in 3 quarters since.
  • Atria Investments's Altimmune position peaked at $86.8K in Q2 2024.
  • 210 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.